65,437 trials
Pancreatic Adenocarcinoma
Primary: Change From Baseline in Summed Standardized Uptake Value (SUVmax) of Lesion After 2 Cycles of Chemotherapy — 27.45 percentage of SUV Max change
Breast Cancer · Joint Pain
Primary: Change in WOMAC Score — 24.9 Score on a scale — p=0.004
Refractive Errors · Ametropia · Myopia
Primary: Least Squares Mean Distance VA (logMAR) With Study Lenses — -0.10; -0.10 logMAR
Tobacco Use, Cigarette Use
Primary: Very Low Nicotine Content (VLNC) Misperception — 3.12; 3.04; 3.04; 3.36 score on a scale
Polycystic Kidney, Autosomal Dominant
Primary: Phase 1b: Number of Participants With Treatment-emergent Adverse Events (TEAEs) and Serious Adverse Events (SAE) — 24; 8; 5; 1 Participants
Pain, Postoperative
Primary: The Number of Patients With Requests for Breakthrough Opioid Pain Medication in Opioid Standard of Care Regimen Compared to Non-opioid Multimodal Pain Relief Regimen…
Sickle Cell Disease
Primary: Number of Participants With Graft Failure — 3 Participants
Influenza · Vaccination · Health Promotion
Primary: Flu Vaccination Rate — 4901; 5042; 5087; 5090 Participants — p=0.0035
Caregiver Burnout
Primary: Percentage of Participants Able to Opt Into CuidaTXT (Enrollment Feasibility) — 24 Participants
Liver Cancer
Primary: Progression Free Survival (PFS) — 43 months
Chronic Low Back Pain
Primary: Percent Change in Pain Assessed by Visual Analogue Scale (VAS) — -0.0145; -0.2082; -0.1109 percentage of pain change
Cervical Adenocarcinoma · Cervical Adenosquamous Carcinoma · Cervical Squamous Cell Carcinoma, Not Otherwise Specified
Primary: Overall Survival Rate at 5 Years — 71; 72 Percentage of participants
Obesity
Primary: Body Weight — 99.8; 101.0 kilogram (kg) — p=0.001
Alcohol Use, Unspecified
Primary: Alcohol Use — 7.4; 5.3; 4.4 drinks per episode
Pulmonary Embolism · Chronic Obstructive Pulmonary Disease
Primary: All-cause Mortality, Symptomatic Venous Thromboembolism Recurrence, or Need for Readmission. — 110; 107 Participants